Spyre Therapeutics (SYRE) Q3 2020 Earnings

5NovExpected
Q4 2019
Q1 2020
Q2 2020
Q3 2020
-16.25
-10.96
-5.68
-0.39

Details

Expected EPS
-0.3917
Actual EPS
-7.25
Surprise EPS
-6.86
Surprise Percent
+1,750.91%

Description

Spyre Therapeutics (SYRE) has reported earnings of -7.25 per share for Q3 2020.

0 Comments

Share your thoughts